Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1
- 31 March 2008
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 108 (3) , 609-618
- https://doi.org/10.1016/j.ygyno.2007.11.007
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- The deficiency ofAkt1is sufficient to suppress tumor development inPten+/−miceGenes & Development, 2006
- Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathwaysMolecular Cancer Therapeutics, 2006
- Practicalities of Drugging the Phosphatidylinositol-3-Kinase/Akt Cell Survival Signaling PathwayClinical Cancer Research, 2006
- Biologic targets for therapeutic intervention in endometrioid endometrial adenocarcinoma and malignant mixed müllerian tumorsAmerican Journal of Obstetrics and Gynecology, 2006
- FOXO1a acts as a selective tumor suppressor in alveolar rhabdomyosarcomaThe Journal of cell biology, 2005
- AKT involvement in cisplatin chemoresistance of human uterine cancer cellsGynecologic Oncology, 2004
- Interleukin-3-Induced Phosphorylation of BAD Through the Protein Kinase AktScience, 1997
- Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death MachineryCell, 1997
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997